What We DO and DON’T like about the proposed CPH Merger
Email Jun 17, 2021
Today Creso Pharma (ASX: CPH | OTC: COPHF) announced its plans to merge with a Canadian listed psychedelics company called Red Light Holland.
Email Jun 17, 2021
Today Creso Pharma (ASX: CPH | OTC: COPHF) announced its plans to merge with a Canadian listed psychedelics company called Red Light Holland.
Email Jan 19, 2021
Today Creso Pharma (ASX: CPH) reported new and follow up Purchase Orders for its animal health medicinal cannabis products totalling over A$345,000.
Article Archived Mar 04, 2020
Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.
Article Archived Feb 06, 2020
Hot on the heels of major developments in human and animal health, Creso Pharma (ASX:CPH) has achieved another key milestone: a technological breakthrough that will expand its cannaQIX® human health product line,
Article Archived Jan 21, 2020
Momentum has been building over the last couple of months as CresoPharma (ASX:CPH) outlined its strategy for generating substantial growth in 2020.
Article Archived Dec 03, 2019
Through partnerships with leading global companies, Creso Pharma (ASX:CPH) has been able to, and will continue to accelerate the development and distribution of its products worldwide.
Article Archived Oct 16, 2019
Roots Sustainable Agricultural Technologies' (ASX:ROO) upgraded Root Zone Temperature Optimisation (RZTO) cooling system has just been shown to double the dry flower yield in some strains of greenhouse-grown cannabis in Southern California.
Article Archived Aug 21, 2019
Making waves in the ASX pot stock space is award-winning global agronomy, farm management and agtech company, CropLogic Limited (ASX:CLI) — it's been on a run, making higher-highs and higher-lows since February and rewarding shareholders with a more than 550% gain all up.
Article Archived Jun 21, 2019
Roots Sustainable Agricultural Technologies (ASX:ROO) has today penned a new US sales agreement with a Californian cannabis producer, delivering technology that brings measurable yield improvements for cannabis crops..
Article Archived Dec 11, 2018
BPH Energy (ASX:BPH) is not your average speculative junior. While the company has exposure to the oil and gas sector, it is BPH’s investments in the medtech and biotech sectors that the company is currently more focussed on.
Article Archived Oct 18, 2018
This week, Canada has become the second country in the world — and the first industrialised nation — to legalise recreational cannabis use nationwide. ASX cannabis innovator, Creso Pharma (ASX:CPH), has welcomed this change with open arms.
Article Archived Sep 05, 2018
Creso Pharma (ASX:CPH) is one step closer to launching its range of cannabis infused products.
Article Archived Aug 28, 2018
Since we last checked in with rapidly blossoming ag-tech play, Roots Sustainable Agricultural Technologies (ASX:ROO), it has been flush with good news.
Article Archived Jul 13, 2018
Nimble ASX pot-stock MGC Pharmaceuticals (ASX:MXC) this week smashed a pivotal milestone, scoring full manufacturing licence for its world-class European compounding and manufacturing facility for the production of euGMP grade medicinal cannabis products.
Article Archived Jul 09, 2018
Roots (ASX:ROO) has reached an agreement with Canndoc Limited, one of Israel’s leading medical cannabis growers, to use its technology to conduct a world-first proof of concept to cool medical cannabis roots grown in a greenhouse in northern Israel.
Article Archived Jul 02, 2018
Roots (ASX:ROO) is launching into the medical cannabis market, after reaching an agreement to conduct a pilot with American Farms Consulting LLC (AFC) to use its patented Root Zone Temperature Optimisation (RZTO) technology.
Article Archived May 16, 2018
Creso Pharma (ASX:CPH) has today informed the market that it has entered into a joint venture with Cohen Propagation Nurseries Limited to operate a high quality medicinal cannabis growing facility in Israel.
Article Archived Apr 12, 2018
MGC Pharmaceuticals (ASX:MXC) has wasted no time ramping up its game in 2018.